LSU Health New Orleans receives $3.1M grant to study head-and-neck cancer incidence in people living with HIV

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

The National Institute of Dental and Craniofacial Research awarded a $3 million grant to researchers from Henry Ford Health + Michigan State University Health Sciences to study new treatments for patients who have head-and-neck cancer caused by HPV.

July 25, 2025

Vol.51 No.29

Capitol Hill

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

June 27, 2025

Vol.51 No.25

By Claire Marie Porter

Clinical Roundup

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Mayo Clinic researchers have established the world’s first biobank of human salivary gland tissue-organoids to study chronic dry mouth, or xerostomia, an agonizing side effect of damaged salivary glands that affects millions.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Pembro + standard-of-care improves survival in locally advanced head-and-neck cancer

An international clinical trial co-led by WashU Medicine found that the immunotherapy drug pembrolizumab (Keytruda) added to standard-of-care therapy improved survival for patients with locally advanced head-and-neck cancer.

May 02, 2025

Vol.51 No.17

Clinical Roundup

Chemo-immunotherapy approach shows potential benefit in advanced HPV-negative head-and-neck cancer

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus-negative head-and-neck squamous cell carcinoma. More than half of study participants had 50% or more of their tumors shrink after receiving the immunotherapy drug nivolumab with chemotherapy, followed by response-adaptive chemo-radiation therapy.

March 14, 2025

Vol.51 No.10

Clinical Roundup

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Cedars-Sinai performed the first robot-assisted microsurgical head-and-neck cancer reconstructive surgery in the United States after the robot device received FDA approval for the procedure.

February 21, 2025

Vol.51 No.07

LSU Health New Orleans receives $3.1M grant to study head-and-neck cancer incidence in people living with HIV

YOU MAY BE INTERESTED IN

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Pembro + standard-of-care improves survival in locally advanced head-and-neck cancer

Chemo-immunotherapy approach shows potential benefit in advanced HPV-negative head-and-neck cancer

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Renew today!

Subscriber content

Never miss an issue!

Login

LSU Health New Orleans receives $3.1M grant to study head-and-neck cancer incidence in people living with HIV

YOU MAY BE INTERESTED IN

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policiesRep. Lori Trahan: “People are going to die”

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Pembro + standard-of-care improves survival in locally advanced head-and-neck cancer

Chemo-immunotherapy approach shows potential benefit in advanced HPV-negative head-and-neck cancer

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Never miss an issue!

Login

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”